Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.
NEW YORK STATE ASSEMBLY MEMORANDUM IN SUPPORT OF LEGISLATION submitted in accordance with Assembly Rule III, Sec 1(f)
BILL NUMBER: A10083
SPONSOR: Rajkumar TITLE OF BILL:
An act to amend the education law, in relation to the dispensing of
certain prescriptions
PURPOSE OR GENERAL IDEA OF BILL:
To allow providers prescribing medication abortion to request that the
pharmacy exclude certain identifying information on prescription labels,
or if they dispense the drugs themselves, allow them to exclude such
information.
SUMMARY OF PROVISIONS:'
Section 1 amends paragraph b-1 of subdivision 1 of section 6807 of the
education law to allow individuals dispensing medication abortion to
omit the name and address of the dispenser and patient, provided that
the label includes a prescription number or other means of identifying
the prescription. Providers must keep a log of all prescriptions filled
under these protections for at least five years. Such records are
subject to the protections of the state's abortion shield law.
Section 2 amends subdivision 1-a of section 6810 of the education law
to' require that when requested by the prescriber, pharmacies exclude
the name and address of the prescriber, patient, and pharmacy when
dispensing medication abortion. Such information must be maintained in
pharmacy logs of filled prescriptions and is subject to the projections
of the shield law.
Section 3 provides the effective date.
DIFFERENCE BETWEEN ORIGINAL AND AMENDED VERSION (IF APPLICABLE):
JUSTIFICATION:
Since the Supreme Court's disastrous decision to revoke the constitu-
tional right to an abortion in Dobbs vs. Jackson Women's Health Organ-
ization in June 2022, states around the country have moved to restrict
access to abortion. As of November 2024, nineteen states ban abortion
under twelve weeks. Thirteen of those states have functionally a full
ban; another four ban abortion after 6 weeks, when few women even know
they are pregnant.' Over half of women between the ages of 18-49 live in
a state with some restrictions on abortion care.
Medication abortion has become a lifeline for many individuals seeking
abortions in hostile states. In 2023, New York passed a telehealth
shield law (Chapter 138 of the laws of 2023) to provide broad protection
to doctors based in New York serving patients in those states via tele-
health. These protections include shielding New York health care practi-
tioners against states that may try to impose civil or criminal sanc-
tions upon them and protection from professional disciplinary action or
adverse action from medical malpractice insurers.
Thanks to New York's shield law, providers based in New York are able to
send thousands of abortion pills to patients based in hostile states
each month, helping women who may not otherwise be able to access
abortion care. According to research by the Society for Family Planning,
in the first six months of 2025, 27% of abortions nationally were
provided via telehealth. In states where abortion is banned, telehealth
makes up nearly 100% of abortions. (A small number are provided under
exceptions to some state laws). As of June 2025, the Society for Family
Planning estimates that 55% of telehealth abortions are being provided
from states with shield laws like New York's.
In response to escalating threats to telehealth providers, in 2025 New
York strengthened its telehealth shield law, including by allowing phar-
macies and prescribers filling prescriptions to use the name of the
prescribing doctor's practice rather than their name on the prescription
label (Chapter 7 of the laws of 2025). Unfortunately, attacks on provid-
ers serving women through telehealth have only increased since then.
This legislation provides further protections for providers and patients
taking advantage of telehealth care. It would allow prescribers to
request that a pharmacy exclude their name and the name and address of
the patient and pharmacy when filling a prescription for medication
abortion. Similarly, doctors dispensing medication abortion would be
allowed to exclude their and their patient's name and address from the
prescription label. Pharmacies and doctors would be required to keep
records of their prescriptions for five years which would be subject to
the existing protections of New York's shield law. Similar protections
were adopted by California in September of 2025 (Chapter 136 of
California's laws of 2025).
PRIOR LEGISLATIVE HISTORY:
New bill
FISCAL IMPLICATIONS FOR STATE AND LOCAL GOVERNMENTS:
None
EFFECTIVE DATE:
This act shall take effect immediately
STATE OF NEW YORK
________________________________________________________________________
10083
IN ASSEMBLY
January 30, 2026
___________
Introduced by M. of A. RAJKUMAR -- read once and referred to the Commit-
tee on Higher Education
AN ACT to amend the education law, in relation to the dispensing of
certain prescriptions
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Paragraph b-1 of subdivision 1 of section 6807 of the
2 education law, as amended by chapter 108 of the laws of 2025, is amended
3 to read as follows:
4 b-1. (1) Notwithstanding paragraph b of this section, [the
5 prescription label for] mifepristone or misoprostol may [include the
6 name or address of the dispensing health care practice instead of the
7 name of the dispenser] be dispensed without the name and address of the
8 dispenser and patient included on the prescription label, provided that
9 such label includes a prescription number or other means of identifying
10 the prescription.
11 (2) Any person who dispenses mifepristone or misoprostol pursuant to
12 this paragraph shall maintain a log with the prescription numbers, name
13 and address of the dispenser and patient, and information otherwise
14 required on the prescription label pursuant to paragraph b of this
15 subdivision. Such log shall include records for a period of at least
16 five years following the date such prescription is dispensed.
17 (3) Nothing in this paragraph shall be construed to prohibit the
18 investigation of an activity that is punishable as a crime under the
19 laws of this state, provided that only such records that are strictly
20 necessary to the investigation of such potential crime shall be
21 disclosed.
22 § 2. Subdivision 1-a of section 6810 of the education law, as amended
23 by chapter 108 of the laws of 2025, is amended to read as follows:
24 1-a. Notwithstanding subdivision one of this section, at the
25 prescriber's request, [the prescription label for] mifepristone or miso-
26 prostol shall [include the name or address of the prescribing health
27 care practice instead of the name of the prescriber] be dispensed with-
28 out the name and address of the owner of the establishment in which it
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD14047-04-6
A. 10083 2
1 was dispensed, the name of the prescriber, and the name and address of
2 the patient included on the prescription label, provided that such
3 information is recorded and maintained by the pharmacist pursuant to
4 subdivision five of this section. Nothing in this subdivision shall
5 be construed to prohibit the investigation of an activity that is
6 punishable as a crime under the laws of this state, provided that
7 only such records maintained pursuant to subdivision five of this
8 section that are strictly necessary to the investigation of such
9 potential crime shall be disclosed.
10 § 3. This act shall take effect immediately.
